Features, pricing, ratings, and pros & cons — compared head-to-head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). AVG AntiVirus FREE is a commercial endpoint protection platform tool by AVG. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Startups and small teams with Windows-heavy fleets and minimal security staff should use AVG AntiVirus FREE for its low friction deployment and genuine real-time scanning; the free tier removes budget friction while multi-platform support (Windows, Mac, Android, iOS) covers the sprawl most SMBs actually face. The threat detection network feeds continuous updates, so you're not managing signature releases manually. Skip this if you need endpoint detection and response or compliance reporting; AVG covers Detect well through continuous monitoring but has no recovery or Respond capabilities, making it insufficient for teams that need post-breach investigation or forensics.
Tool that immunizes Windows systems against critical vulnerabilities
Free antivirus software for virus scanning, detection, and removal
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs AVG AntiVirus FREE for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
AVG AntiVirus FREE: Free antivirus software for virus scanning, detection, and removal. built by AVG. Core capabilities include Virus scanning and detection, Malware removal and quarantine, Real-time threat protection..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. AVG AntiVirus FREE differentiates with Virus scanning and detection, Malware removal and quarantine, Real-time threat protection.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). AVG AntiVirus FREE is developed by AVG. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
360 High-Risk Vulnerability Immunization Tool V2.0 and AVG AntiVirus FREE serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox